Do clinically actionable gene variants in South Asian Indian patients with hypertrophic cardiomyopathy differ from other global cohorts?
South Asian Indian patients with hypertrophic cardiomyopathy have a significantly different profile of clinically actionable gene variants (MYBPC3, MYH7, MYH6) compared to other global cohorts.
The clinically actionable gene variants in SAI HCM differed significantly from other global HCM cohorts, specifically MYBPC3, MYH7, and MYH6.
Rao et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: